China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Health Management Needs and Navigation Matrix Model for Patients with ... Read More
China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Human Efficacy Trial of Combined Hengfu Soft Capsule and Yirui Capsule'. The following... Read More
China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy of a Fish Oil-Containing Medium- and Long-Chain Triglyceride Lipid Emulsion i... Read More
China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Study of the Association of Fecal Calprotectin with Disease Activity, MR... Read More
China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Application of Wide-Field Retinal Refraction Topography in the Evaluation of Visual Qu... Read More
China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Precise Targeted Brain Stimulation Technology Guided by Brain Imaging and Its Applied ... Read More
China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical study on the detection of tumor PD-L1 expression based on new-type PET/CT ima... Read More
China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An Observational Study of Portal Venous Circulating Tumor Cells and Associated Metasta... Read More
China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Predictors of Immediate Tinnitus Relief After Short-Term Modulated Acoustic Interventi... Read More
China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective clinical study of Sacituzumab Tirumotecan combined with Pembrolizumab in... Read More